Literature DB >> 17422189

Study of serum drug levels in calves following intramuscular administration of three tetracycline drug preparations.

W D Black, J Claxton, G A Robinson.   

Abstract

Three antibiotic formulations, oxytetracycline (A) in propylene glycol and oxytetracycline (B) in polyvinyl pyrrolidine and pyrrolidino-methyltetracycline in an oil suspension were given to calves by the intramuscular route. Only oxytetracycline (A) appeared to cause much pain after injection.The half-time elimination (t((1/2)cl)) for oxytetracycline (A) was 14.000 +/- 3.580 h for oxytetracycline (B) 10.290 +/-5.159 h and for pyrrolidinomethyltetracycline 8.160 +/- 0.920 h. The rate of elimination ;beta slope" for oxytetracycline (A) was 0.052 +/- 0.012 h(-1) for oxytetracycline (B) 0.077 +/- 0.261 h(-1) and for pyrrolidinomethyltetracycline 0.086 +/- 0.010 h(-1). The Y intercept of the "beta" elimination slope C(os) (mug/mL) for oxytetracycline (A) was 2.490 +/- 1.040, for oxytetracycline (B) 3.463 +/- 1.874 and for pyrrolidinomethyltetracycline 2.852 +/- 1.360.Pyrrolidinomethyltetracycline appeared to have a two component elimination curve, however, only the "beta slope" was used for the calculations.

Entities:  

Year:  1982        PMID: 17422189      PMCID: PMC1790220     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  4 in total

1.  Pharmacokinetics, plasma protein binding and dosage of oxytetracycline in cattle and horses.

Authors:  M Pilloud
Journal:  Res Vet Sci       Date:  1973-09       Impact factor: 2.534

2.  Analysis of pharmacokinetic properties of nine tetracycline analogues in dairy cows and ewes.

Authors:  G Ziv; F G Sulman
Journal:  Am J Vet Res       Date:  1974-09       Impact factor: 1.156

3.  Outline of details for microbiological assays of antibiotics: second revision.

Authors:  B Arret; D P Johnson; A Kirshbaum
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

4.  Bovine blood serum concentrations of terramycin (Oxytetracycline) following intravenous and intramuscular administration.

Authors:  H W YODER; R A PACKER
Journal:  Am J Vet Res       Date:  1954-07       Impact factor: 1.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.